PEOPLE - Neoprobe (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Oncology and cardiovascular surgical and diagnostic developer Neoprobe (Dublin, Ohio) has appointed Carl Aschinger to its board of directors. His term runs until 2005, when he will stand for election for another term ending in 2008. Mr Aschinger has been a member of the board of directors of several Columbus, Ohio-based companies.